EMBL: 'Well Prepared' to Address 'Big' Science Despite Loss Due to Dip in EC Funding | GenomeWeb

By Alex Philippidis

NEW YORK (GenomeWeb News) — The European Molecular Biology Laboratory is "well prepared" to tackle challenges posed by the growth of 'big' science as it begins planning its research and operations strategy for the five years starting in 2012, Director General Iain Mattaj said in the institution's annual report for the fiscal year ended March 31.

The report showed a decline in grant funding, especially by the European Community, that pushed EMBL into the red.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.